Literature DB >> 11422945

Pathogen inactivation of labile blood products.

.   

Abstract

Mesh：

Year:  2001        PMID： 11422945     DOI： 10.1046/j.1365-3148.2001.00310.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN： 0958-7578            Impact factor:   2.019


× No keyword cloud information.
  4 in total

1.  The challenge of an increasingly expensive blood system.

Authors:  Kumanan Wilson; Paul C Hébert
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

Review 2.  Blood transfusion medicine.

Authors:  Fiona Regan; Clare Taylor
Journal:  BMJ       Date:  2002-07-20

3.  Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis.

Authors: 
Journal:  CADTH Technol Overv       Date:  2010-03-01

4.  Variant Creutzfeldt-Jakob disease and the Canadian blood system after the tainted blood tragedy.

Authors:  Kumanan Wilson; Ian Graham; Maura Ricketts; Christopher Dornan; Andreas Laupacis; Paul Hebert
Journal:  Soc Sci Med       Date:  2006-10-02       Impact factor: 4.634
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.